Venture Round - ViAqua Therapeutics

Venture Round - ViAqua Therapeutics

Investment Firm

Overview

ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.

Announced Date

Sep 05, 2023

Closed on Date

Sep 05, 2023

Funding Type

Series Unknown

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

S2G Ventures

S2G Ventures

S2G Ventures is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorI-Lab Angels
Participant InvestorCircle Investments
Participant InvestorTrendlines Group
Participant InvestorRabo Ventures
Participant InvestorS2G Ventures

Round Details and Background

ViAqua Therapeutics raised $8250000 on 2023-09-05 in Venture Round

ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 13, 2018
Venture Round - ViAqua Therapeutics
1-undefined
Jun 09, 2021
Venture Round - ViAqua Therapeutics
7-4.3M
Jun 09, 2021
Grant - ViAqua Therapeutics
1-undefined
Sep 05, 2023
Venture Round - ViAqua Therapeutics
7-8.3M

Recent Activity

There is no recent news or activity for this profile.